SCHEMBL29532002

SCHEMBL29532002

CCCCCN1Cc2ccccc2C1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.60
DRD5 P21918 4/20 0.60
DRD3 P35462 4/20 0.60
HTR1A P08908 1/20 0.60
HTR7 P34969 2/20 0.59
KDM4E B2RXH2 1/20 0.59
ALOX15 P16050 1/20 0.59
TSHR P16473 1/20 0.59
SIRT1 Q96EB6 1/20 0.59
HDAC3 O15379 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52
HDAC11 Q96DB2 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
HDAC9 Q9UKV0 1/20 0.52
HDAC5 Q9UQL6 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18030756 1.00 DRD2 (0.60) DRD2DRD5DRD3HTR1AHTR7
SCHEMBL18612248 0.98 HTR7 (0.61) DRD2DRD5DRD3HTR1AHTR7
SCHEMBL29531994 0.98 HTR7 (0.61) DRD2DRD5DRD3HTR1AHTR7
SCHEMBL13910341 0.98 HTR7 (0.61) DRD2DRD5DRD3HTR1AHTR7
SCHEMBL20329971 0.98 HTR7 (0.61) DRD2DRD5DRD3HTR1AHTR7
SCHEMBL29531631 0.95 KDM4E (0.60) DRD2DRD5DRD3HTR1AHTR7
SCHEMBL22291829 0.95 KDM4E (0.60) DRD2DRD5DRD3HTR1AHTR7
SCHEMBL8242914 0.88 KDM4E (0.64) DRD2DRD5DRD3HTR1AHTR7
SCHEMBL31252767 0.88 KDM4E (0.64) DRD2DRD5DRD3HTR1AHTR7
SCHEMBL4552575 0.84 DRD3 (0.60) DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12459921-B2 Isoindoline compound, preparation method, pharmaceutical composition and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2025-11-04 US disclosed
US-20220041576-A1 ISOINDOLINE COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2022-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12459921-B2 Isoindoline compound, preparation method, pharmaceutical composition and use thereof CUL4B, CUL4A, UBQLN1 DRD2 1463/4885DRD5 822/4885DRD3 1898/4885
US-20220041576-A1 ISOINDOLINE COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF CUL4B, CUL4A, UBQLN1 DRD2 1463/4885DRD5 822/4885DRD3 1898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.